Medtech Development
ActiveSummary
Medtech Development has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€2,500) and a net result of -€5,000. Its solvency ranks better than 5% of 10,686 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Financials · financial year 2025, abbreviated format
2025 annual accounts filed late (29 days) Filed on 29 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00450749.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Peer companies
Historical observationOf the 1,322 companies that looked in July 2024 the way this one looks now, 4.2% went bankrupt within 24 months and 90.2% are still going.
- Micro
- under 2 years old
- negative equity
- a loss of 10% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,472 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,322 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Gross operating margin9900 | -€4,288 |
| Operating profit (loss)9901 | -€4,288 |
| Financial charges65/66B | €712 |
| Recurring financial charges65 | €712 |
| Profit (loss) for the period before taxes9903 | -€5,000 |
| Profit (loss) for the period9904 | -€5,000 |
| Profit (loss) for the period to be appropriated9905 | -€5,000 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €2,405 | |
| Current assets29/58 | €2,405 | |
| Cash at bank and in hand54/58 | €2,405 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €2,405 | |
| Equity10/15 | -€2,500 | |
| Contributions10/11 | €2,500 | |
| Contributions outside capital11 | €2,500 | |
| Other1109/19 | €2,500 | |
| Profit (loss) carried forward14 | -€5,000 | |
| Amounts payable17/49 | €4,905 | |
| Amounts payable within one year42/48 | €4,905 | |
| Trade debts44 | €357 | |
| Suppliers440/4 | €357 | |
| Taxes, remuneration and social security45 | €52 | |
| Taxes450/3 | €52 | |
| Other amounts payable47/48 | €4,496 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | -€5,000 |
| Operating cash flow (approximation) | -€5,000 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 29-08-2026 | 2026-00450749 |
Similar companies · same sector and region
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.